A novel approach reveals that HLA class 1 single antigen bead-signatures provide a means of high-accuracy pre-transplant risk assessment of acute cellular rejection in renal transplantation
Authors:
- Nicole WittenbrinkNWNicole Wittenbrink
- Sabrina HerrmannSHSabrina Herrmann
- Arturo Blazquez-NavarroABArturo Blazquez-Navarro
- Chris BauerCBChris Bauer
- Eric LindbergELEric Lindberg
- Kerstin WolkKWKerstin Wolk
- Robert SabatRSRobert Sabat
- Petra ReinkePRPetra Reinke
- Birgit SawitzkiBSBirgit Sawitzki
- Oliver ThomuschOTOliver Thomusch
- Christian HugoCHChristian Hugo
- Nina BabelNBNina Babel
Open Access
- 27 April 2019
- journal article
- research article
- Published by Springer Nature in BMC Immunology
- Vol. 20 (1) , 11
Abstract
Acute cellular rejection (ACR) is associated with complications after kidney transplantation, such as graft dysfunction and graft loss. Early risk assessment is therefore critical for the improvement of transplantation outcomes. In this work, we retrospectively analyzed a pre-transplant HLA antigen bead assay data set that was acquired by the e:KID consortium as part of a systems medicine approach. The data set included single antigen bead (SAB) reactivity profiles of 52 low-risk graft recipients (negative complement dependent cytotoxicity crossmatch, PRA < 30%) who showed detectable pre-transplant anti-HLA 1 antibodies. To assess whether the reactivity profiles provide a means for ACR risk assessment, we established a novel approach which differs from standard approaches in two aspects: the use of quantitative continuous data and the use of a multiparameter classification method. Remarkably, it achieved significant prediction of the 38 graft recipients who experienced ACR with a balanced accuracy of 82.7% (sensitivity = 76.5%, specificity = 88.9%). The resultant classifier achieved one of the highest prediction accuracies in the literature for pre-transplant risk assessment of ACR. Importantly, it can facilitate risk assessment in non-sensitized patients who lack donor-specific antibodies. As the classifier is based on continuous data and includes weak signals, our results emphasize that not only strong but also weak binding interactions of antibodies and HLA 1 antigens contain predictive information. ClinicalTrials.gov NCT00724022 . Retrospectively registered July 2008.Keywords
All Related Versions
Funding Information
- Bundesministerium für Forschung, Technologie und Raumfahrt (01ZX1312)
This publication has 59 references indexed in Scilit:
- Decision tree and random forest models for outcome prediction in antibody incompatible kidney transplantationBiomedical Signal Processing and Control, 2019
- BKV, CMV, and EBV Interactions and their Effect on Graft Function One Year Post-Renal Transplantation: Results from a Large Multi-Centre StudyEBioMedicine, 2018
- Clinically-relevant threshold of preformed donor-specific anti-HLA antibodies in kidney transplantationHuman Immunology, 2016
- Immune mechanisms of acute and chronic rejectionClinical Biochemistry, 2016
- The perfect storm: HLA antibodies, complement, FcγRs, and endothelium in transplant rejectionTrends in Molecular Medicine, 2015
- Feasibility of an early Alzheimer's disease immunosignature diagnostic testJournal of Neuroimmunology, 2013
- Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survivalHuman Immunology, 2009
- Pre-transplant and post-transplant soluble CD30 for prediction and diagnosis of acute kidney allograft rejectionInternational Urology and Nephrology, 2008
- Lowering the tone: mechanisms of immunodominance among epitopes with low affinity for MHCImmunology Today, 1996
- Affinity and kinetic analysis of the interaction of the cell adhesion molecules rat CD2 and CD48.The EMBO Journal, 1993